The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

The agency said that the test is unnecessary for the screening of whole blood and blood components that are screened with nucleic acid tests and core antigen tests.

The rapid lateral flow assay from Lumos Diagnostics distinguishes bacterial and nonbacterial respiratory infections using a drop of blood.

The US Food and Drug Administration granted clearances for infectious disease tests, digital pathology software, and hematology analyzers, among other in vitro diagnostic technologies.

Agilent Technologies said that Robert McMahon will resign from as the company's senior vice president and chief financial officer, effective July 31 for family reasons. Rodney Gonsalves, Agilent's ...

The Determine Antenatal Care Panel is used for the simultaneous detection of infectious diseases that threaten maternal and pediatric health.

The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...

Last week, readers were most interested in a story about an extended collaboration between Personalis and Tempus to include colorectal cancer.

NEW YORK – Bio-Techne on Tuesday announced a strategic partnership to distribute Spear Bio's immunoassays for detecting low-abundance biomarkers in neurology. The assays include Alzheimer's disease ...